QureInvest

QureInvest is an early-stage venture capital fund and investment company managed by HS LifeSciences, specializing in the biotechnology and pharmaceutical sectors. Founded in 2009 and based in Düsseldorf and Zurich, the firm employs a market-driven approach to value creation by closely linking scientific innovation with business development. QureInvest provides multi-million dollar investments to research-stage companies, helping them reach clinical proof-of-concept and attract major pharmaceutical partners. Its portfolio includes notable biotech firms such as Ethris, ImmunoQure, and Transimmune, focusing on high-impact modalities like mRNA therapeutics and human-derived antibodies. The firm was established by a team of experienced entrepreneurs and investors, including Karsten Henco, the co-founder of Qiagen and Evotec.